Insufficient scRNA-seq data for expression of PDE11A at single-cell level.
Insufficient scRNA-seq data for expression of PDE11A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 1907.23 | 239 / 245 | 71% | 4.00 | 357 / 502 |
pancreas | 99% | 316.84 | 326 / 328 | 40% | 0.68 | 72 / 178 |
kidney | 98% | 154.13 | 87 / 89 | 33% | 0.79 | 296 / 901 |
liver | 100% | 682.98 | 225 / 226 | 27% | 0.77 | 110 / 406 |
thymus | 100% | 321.41 | 650 / 653 | 11% | 0.20 | 69 / 605 |
muscle | 96% | 1041.00 | 770 / 803 | 0% | 0 | 0 / 0 |
brain | 82% | 235.44 | 2174 / 2642 | 10% | 0.16 | 74 / 705 |
breast | 82% | 226.55 | 377 / 459 | 10% | 0.19 | 116 / 1118 |
intestine | 75% | 175.00 | 728 / 966 | 12% | 0.22 | 61 / 527 |
uterus | 75% | 183.29 | 127 / 170 | 9% | 0.27 | 43 / 459 |
adrenal gland | 66% | 75.62 | 170 / 258 | 17% | 0.50 | 40 / 230 |
ovary | 42% | 37.72 | 75 / 180 | 20% | 0.66 | 88 / 430 |
blood vessel | 56% | 68.31 | 746 / 1335 | 0% | 0 | 0 / 0 |
adipose | 47% | 99.95 | 570 / 1204 | 0% | 0 | 0 / 0 |
stomach | 31% | 35.56 | 113 / 359 | 15% | 0.31 | 43 / 286 |
skin | 28% | 29.02 | 515 / 1809 | 13% | 0.46 | 60 / 472 |
heart | 35% | 52.31 | 304 / 861 | 0% | 0 | 0 / 0 |
esophagus | 4% | 3.68 | 51 / 1445 | 21% | 0.48 | 39 / 183 |
bladder | 10% | 9.38 | 2 / 21 | 2% | 0.04 | 9 / 504 |
lung | 0% | 0.32 | 2 / 578 | 5% | 0.10 | 61 / 1155 |
spleen | 0% | 0.63 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.11 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0019933 | Biological process | cAMP-mediated signaling |
GO_0043951 | Biological process | negative regulation of cAMP-mediated signaling |
GO_0010754 | Biological process | negative regulation of cGMP-mediated signaling |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0047555 | Molecular function | 3',5'-cyclic-GMP phosphodiesterase activity |
GO_0004114 | Molecular function | 3',5'-cyclic-nucleotide phosphodiesterase activity |
GO_0004115 | Molecular function | 3',5'-cyclic-AMP phosphodiesterase activity |
GO_0030553 | Molecular function | cGMP binding |
GO_0004112 | Molecular function | cyclic-nucleotide phosphodiesterase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0004118 | Molecular function | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity |
Gene name | PDE11A |
Protein name | Phosphodiesterase 11A Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A) Phosphodiesterase (EC 3.1.4.-) Uncharacterized protein PDE11A |
Synonyms | |
Description | FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides cAMP and cGMP . Catalyzes the hydrolysis of both cAMP and cGMP to 5'-AMP and 5'-GMP, respectively . . |
Accessions | ENST00000433879.1 H0Y6P9 E9LCZ2 ENST00000409504.5 [Q9HCR9-3] E9LCZ3 Q9HCR9 ENST00000358450.8 [Q9HCR9-2] H7C4D0 ENST00000436700.5 Q53S13 ENST00000389683.7 [Q9HCR9-4] ENST00000286063.11 [Q9HCR9-1] F8WDQ4 Q53S07 ENST00000427127.1 |